Fish oil supplements, long promoted as a brain-boosting staple for millions, may actually hinder the brain’s ability to repair itself after injury, according to latest research from the Medical University of South Carolina. The study, published in Cell Reports, focuses on eicosapentaenoic acid (EPA), one of the two primary omega-3 fatty acids in fish oil, and finds that while docosahexaenoic acid (DHA) supports brain cell membranes, EPA may impair recovery processes following traumatic brain injury.
The research, led by Onder Albayram, associate professor at the Medical University of South Carolina, used animal models to examine how EPA affects neurological recovery after repeated mild traumatic brain injuries. Findings showed that EPA supplementation was associated with increased accumulation of tau protein—a toxic marker linked to Alzheimer’s disease and chronic traumatic encephalopathy (CTE)—as well as weakened signaling for blood vessel repair and disrupted metabolic function in the brain.
Despite these findings, Albayram emphasized that the results do not mean healthy individuals should stop taking fish oil. “I am not saying fish oil is inherently good or bad,” he stated. “Our data emphasizes that biology is context-dependent. We cannot assume one supplement has the same effect for everyone.” The study highlights the importance of personalized approaches to supplementation, particularly for those with existing brain injuries.
The study adds to growing scrutiny of omega-3 supplements, which are taken by an estimated 19 million Americans daily, according to recent reports. While fish oil has been widely marketed for heart health, inflammation reduction, and cognitive support, emerging evidence suggests its effects may vary significantly based on individual health status and neurological condition.
Understanding the Role of EPA in Brain Injury Recovery
EPA and DHA are both classified as omega-3 fatty acids, but they play different roles in the body. DHA is a structural component of brain cell membranes and is often associated with cognitive function and neuronal integrity. EPA, meanwhile, is known for its anti-inflammatory properties and is frequently studied in relation to cardiovascular health and mood regulation.
Though, the Medical University of South Carolina research indicates that in the context of brain trauma, EPA may interfere with natural repair mechanisms. Specifically, the study found that EPA did not integrate effectively into brain cells and instead exacerbated processes that hinder recovery. These include promoting tau protein buildup, reducing genetic signals responsible for vascular repair, and shifting the brain’s metabolism toward fat-based energy production—a change that may contribute to metabolic dysfunction.
These effects were observed in animal models subjected to repeated mild traumatic brain injuries, a condition relevant to athletes, military personnel, and others at risk of chronic head trauma. The researchers noted that this is the first study to explore the brain’s “resistance or resilience” to fish oil supplementation, opening new questions about how nutrients interact with injured neural tissue.
Implications for Athletes, Veterans, and Aging Populations
The findings carry particular weight for populations at high risk of repetitive brain injury, such as football players, boxers, and military service members exposed to blast trauma. In these groups, chronic traumatic encephalopathy—a degenerative brain disease linked to repeated head impacts—has become a growing concern. The accumulation of tau protein, which the study associates with EPA exposure, is a pathological hallmark of CTE.
Older adults may too be affected, as age-related cognitive decline and vascular health are closely tied to brain resilience. While omega-3s are often recommended to support aging brains, the study suggests that the balance between EPA and DHA may matter more than previously understood, especially in individuals with pre-existing neurological vulnerabilities.
Albayram and his team, which included collaborators from Cold Spring Harbor Laboratory and other institutions, stressed that more research is needed to determine optimal omega-3 formulations for different health contexts. They called for future studies to examine how dosage, ratio of EPA to DHA, and timing of supplementation influence outcomes in both injured and healthy brains.
What Consumers Should Know About Fish Oil Supplementation
For the general public, the takeaway is not to abandon fish oil outright but to approach supplementation with greater awareness. Health professionals recommend consulting a physician before starting or continuing any supplement regimen, especially for individuals with a history of concussions, neurodegenerative disease, or metabolic disorders.
Consumers are also encouraged to glance beyond marketing claims and examine product labels for the specific amounts of EPA and DHA. Some high-EPA formulations may be better suited for inflammatory conditions like rheumatoid arthritis, while higher-DHA options may be preferable for neurological support—though even this distinction requires further validation in clinical settings.
Regulatory agencies such as the U.S. Food and Drug Administration (FDA) do not approve fish oil supplements for the treatment or prevention of brain injury, and manufacturers are prohibited from making such claims. The FDA advises that supplement labels must include disclaimers stating that products are not intended to diagnose, treat, cure, or prevent any disease.
As research continues to evolve, experts agree that personalized nutrition—guided by medical advice and individual health profiles—represents the safest path forward. Until more definitive human trials are available, caution and informed decision-making remain essential when using fish oil or any dietary supplement.
Related reading